MENU
LTGO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Latigo Biotherapeutics (LTGO) Ownership - Who owns Latigo Biotherapeutics?

Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction... Show more

Profile

Industry
N/A
Address
1300 Rancho Conejo Boulevard
Phone
+1 805 716-2927
Employees
59
Web
https://www.latigobio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.03B
P/E Ratio
-8.41
Total Cash
55M
Projected Growth
N/A
Total Debt
31.25M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.83
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Who owns Latigo Biotherapeutics? LTGO symbol Ownership - Tickeron.com